AXGN FY 2021 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

FY 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$127M+13.4% YoY

Gross Profit

$104M82.0% margin

Operating Income

-$25M-20.0% margin

Net Income

-$27M-21.2% margin

EPS (Diluted)

$-0.65

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$42M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$208M

Total Liabilities

$95M

Stockholders' Equity

$113M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$127M	$112M	+13.4%
Gross Profit	$104M	$91M	+15.1%
Operating Income	-$25M	-$23M	-9.6%
Net Income	-$27M	-$24M	-13.4%